Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease.
Vermunt L, Sutphen C, Dicks E, de Leeuw DM, Allegri R, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Day G, Ewers M, Farlow M, Fox NC, Ghetti B, Graff-Radford N, Hassenstab J, Jucker M, Karch CM, Kuhle J, Laske C, Levin J, Masters CL, McDade E, Mori H, Morris JC, Perrin RJ, Preische O, Schofield PR, Suárez-Calvet M, Xiong C, Scheltens P, Teunissen CE, Visser PJ, Bateman RJ, Benzinger TLS, Fagan AM, Gordon BA, Tijms BM. Vermunt L, et al. Among authors: scheltens p. medRxiv [Preprint]. 2023 Mar 22:2023.03.21.23287468. doi: 10.1101/2023.03.21.23287468. medRxiv. 2023. PMID: 37016671 Free PMC article. Preprint.
Biomarkers for Alzheimer's disease. Which way to go?
Teunissen CE, Scheltens P. Teunissen CE, et al. Among authors: scheltens p. Neurobiol Aging. 2004 Jul;25(6):695-6. doi: 10.1016/j.neurobiolaging.2003.08.013. Neurobiol Aging. 2004. PMID: 15165690 No abstract available.
Use of proteomic approaches to identify disease biomarkers.
Teunissen CE, Scheltens P. Teunissen CE, et al. Among authors: scheltens p. Lancet Neurol. 2007 Dec;6(12):1036-7. doi: 10.1016/S1474-4422(07)70276-4. Lancet Neurol. 2007. PMID: 18031700 No abstract available.
The clinical use of structural MRI in Alzheimer disease.
Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. Frisoni GB, et al. Among authors: scheltens p. Nat Rev Neurol. 2010 Feb;6(2):67-77. doi: 10.1038/nrneurol.2009.215. Nat Rev Neurol. 2010. PMID: 20139996 Free PMC article. Review.
Single-subject grey matter graphs in Alzheimer's disease.
Tijms BM, Möller C, Vrenken H, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F. Tijms BM, et al. Among authors: scheltens p. PLoS One. 2013;8(3):e58921. doi: 10.1371/journal.pone.0058921. Epub 2013 Mar 11. PLoS One. 2013. PMID: 23536835 Free PMC article.
Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease.
Jongbloed W, Bruggink KA, Kester MI, Visser PJ, Scheltens P, Blankenstein MA, Verbeek MM, Teunissen CE, Veerhuis R. Jongbloed W, et al. Among authors: scheltens p. J Alzheimers Dis. 2015;45(1):35-43. doi: 10.3233/JAD-142136. J Alzheimers Dis. 2015. PMID: 25547634
1,264 results